Breast cancer has remained a major public health issue globally but predominantly affects women in developing nations. The overall survival rate of Nigerian women with breast cancer is low and patients with early breast cancer tend to have better survival than those with advanced distic basis and pathology. These changes are leading to revisions in the management of the disease with a positive impact on prognosis.The current research was done to describe the epidemiological and histopathological features of breast cancer amongst females attending the Federal Medical Center, Yenagoa, Bayelsa State, Nigeria. In this retrospective study, 178 breast specimens were used, spanned from 2010 to 2022. Results presented an age at diagnosis lower to the Western population and invasive ductal carcinoma as the main histological type. In this study, the prevalence of breast cancer amongst females attending Federal Medical Center, Yenagoa, Bayelsa State, Nigeria was analyzed using Hematoxylin and Eosin staining techniques on breast cancer samples collected over the study period. The pathophysiology of breast cancer is not very clear; however, some risk factors are. While some common risk factors are advancing age and the female gender, genetic mutations—namely BRCA 1 and 2—account for only about 10% of breast cancers. The role played by biomarkers, such as estrogen receptors, progesterone receptors, and human epidermal growth factor receptors, in the detection and management of patients with breast cancer. Human breast cancer is known to be dependent on sexual hormones for its growth, as it is derived from breast tissue that normally responds to endogenous hormones. Despite improvements in early detection and therapy, Breast Cancer remains one of the major burdens to healthcare systems and societies.